cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccdc.csd.cc2b5q8j
title: CCDC 2150447: Experimental Crystal Structure Determination

description: Related Article: Nataliya E. Borisova, Alexandre M. Fedoseev, Galina V. Kostikova, Petr I. Matveev, Leonid Yu. Starostin, Marina N. Sokolova, Mariia V. Evsiunina|2022|Inorg.Chem.|61|20774|doi:10.1021/acs.inorgchem.2c02578
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2b5qbl
title: CCDC 2150449: Experimental Crystal Structure Determination

description: Related Article: Nataliya E. Borisova, Alexandre M. Fedoseev, Galina V. Kostikova, Petr I. Matveev, Leonid Yu. Starostin, Marina N. Sokolova, Mariia V. Evsiunina|2022|Inorg.Chem.|61|20774|doi:10.1021/acs.inorgchem.2c02578
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2b7dxx
title: CCDC 2152079: Experimental Crystal Structure Determination

description: Related Article: Ziping Li, Dan Wang, Zuohu Zhou, Guiyan Zhao, Qiang Li, Yanfeng Bi, Zhiping Zheng|2022|Inorg.Chem.|61|20814|doi:10.1021/acs.inorgchem.2c03107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2b7dyy
title: CCDC 2152080: Experimental Crystal Structure Determination

description: Related Article: Ziping Li, Dan Wang, Zuohu Zhou, Guiyan Zhao, Qiang Li, Yanfeng Bi, Zhiping Zheng|2022|Inorg.Chem.|61|20814|doi:10.1021/acs.inorgchem.2c03107
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2b7r8m
title: CCDC 2152400: Experimental Crystal Structure Determination

description: Related Article: Rouzbeh Samii, Anton Fransson, Pamburayi Mpofu, Pentti Niiranen, Lars Ojamäe, Vadim Kessler, Nathan J. O’Brien|2022|Inorg.Chem.|61|20804|doi:10.1021/acs.inorgchem.2c03071
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2b7r9n
title: CCDC 2152401: Experimental Crystal Structure Determination

description: Related Article: Rouzbeh Samii, Anton Fransson, Pamburayi Mpofu, Pentti Niiranen, Lars Ojamäe, Vadim Kessler, Nathan J. O’Brien|2022|Inorg.Chem.|61|20804|doi:10.1021/acs.inorgchem.2c03071
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2b7rbp
title: CCDC 2152402: Experimental Crystal Structure Determination

description: Related Article: Rouzbeh Samii, Anton Fransson, Pamburayi Mpofu, Pentti Niiranen, Lars Ojamäe, Vadim Kessler, Nathan J. O’Brien|2022|Inorg.Chem.|61|20804|doi:10.1021/acs.inorgchem.2c03071
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2bhsf2
title: CCDC 2160124: Experimental Crystal Structure Determination

description: Related Article: Febin Kuriakose, Michael Commodore, Chaowei Hu, Catherine J. Fabiano, Debashis Sen, Run R. Li, Shubham Bisht, Ökten Üngör, Xinsong Lin, Geoffrey F. Strouse, A. Eugene DePrince, III, Robert A. Lazenby, Frederic Mentink-Vigier, Michael Shatruk, Igor V. Alabugin|2022|J.Am.Chem.Soc.|144|23448|doi:10.1021/jacs.2c09637
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2bhsg3
title: CCDC 2160125: Experimental Crystal Structure Determination

description: Related Article: Febin Kuriakose, Michael Commodore, Chaowei Hu, Catherine J. Fabiano, Debashis Sen, Run R. Li, Shubham Bisht, Ökten Üngör, Xinsong Lin, Geoffrey F. Strouse, A. Eugene DePrince, III, Robert A. Lazenby, Frederic Mentink-Vigier, Michael Shatruk, Igor V. Alabugin|2022|J.Am.Chem.Soc.|144|23448|doi:10.1021/jacs.2c09637
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.6084/m9.figshare.21393185
title: Proglacial lake expansion and glacier retreat in Arctic Sweden

description: Proglacial lakes have increased in number and extent in Arctic Sweden since the 1950s/1960s as glaciers have retreated dramatically. Interrogation of Rapid Eye imagery highlights that some lake terminating glaciers had substantial (&gt;100 m) rates of retreat between 2010 and 2018, with one other land terminating glacier also retreating at a similar rate. However, analysis of a regional remote sensing time series suggests that proglacial lake formation in this period across the area has not been uniform. Despite glacier accumulation areas having similar maximum elevations (∼2,000 m) and similar alpine topography, proglacial lakes in the southern area (Sarek) were found to be significantly smaller than proglacial lakes in the northern area (Kebnekaise), which had smaller glaciers within corries and more prominent terminal moraines. Therefore, it cannot be assumed that proglacial lake formation will occur as glaciers retreat in response to elevated air temperature, particularly as only 33% of glaciers had proglacial lakes in their forefield. Thus, whilst it cannot be assumed that proglacial lakes will accommodate water currently held in glaciers, the 108 lakes mapped here present a substantial area (4.767 ± 0.377 km<sup>2</sup>) of fresh water that has not previously been included in the Global Lakes and Wetlands Database (GLWD). This inventory therefore provides an important dataset that can be used to underpin our understanding of the role of proglacial lakes within the hydrological system in this area of the Arctic.
DOI: 10.6084/m9.figshare.21393185.v1
title: Proglacial lake expansion and glacier retreat in Arctic Sweden

description: Proglacial lakes have increased in number and extent in Arctic Sweden since the 1950s/1960s as glaciers have retreated dramatically. Interrogation of Rapid Eye imagery highlights that some lake terminating glaciers had substantial (&gt;100 m) rates of retreat between 2010 and 2018, with one other land terminating glacier also retreating at a similar rate. However, analysis of a regional remote sensing time series suggests that proglacial lake formation in this period across the area has not been uniform. Despite glacier accumulation areas having similar maximum elevations (∼2,000 m) and similar alpine topography, proglacial lakes in the southern area (Sarek) were found to be significantly smaller than proglacial lakes in the northern area (Kebnekaise), which had smaller glaciers within corries and more prominent terminal moraines. Therefore, it cannot be assumed that proglacial lake formation will occur as glaciers retreat in response to elevated air temperature, particularly as only 33% of glaciers had proglacial lakes in their forefield. Thus, whilst it cannot be assumed that proglacial lakes will accommodate water currently held in glaciers, the 108 lakes mapped here present a substantial area (4.767 ± 0.377 km<sup>2</sup>) of fresh water that has not previously been included in the Global Lakes and Wetlands Database (GLWD). This inventory therefore provides an important dataset that can be used to underpin our understanding of the role of proglacial lakes within the hydrological system in this area of the Arctic.
DOI: 10.6084/m9.figshare.21804962
title: Geomorphological map of Breiðamerkursandur 2018: the historical evolution of an active temperate glacier foreland

description: We present a geomorphological map of Breiðamerkursandur, the outwash plain and foreland of Breiðamerkurjökull, an outlet glacier of the Vatnajökull ice cap, Southeast Iceland. We trace the glacial retreat of the glacier snout since its historical late nineteenth century Little Ice Age (LIA) maximum extent and the concomitant development of the glacial drainage pathways. Since the outlet began retreating from its LIA terminal position, a 120 km<sup>2</sup> area of foreland has been exposed. The mapped geomorphology is a supplementary continuation of previous surveys in the 20th century, which highlighted the geomorphology and ice margin for the years 1945, 1965 and 1998. Since the 1998 landsystem map, Breiðamerkurjökull has retreated a further 0.6–4.0 km and 29 km<sup>2</sup> has been exposed. This new map was prepared with the use of remote sensing, LiDAR DEM, a range of oblique aerial photographs and satellite images, written documents, in-field survey measurements and refined landform classifications to more accurately trace the position of the retreating snout and its outlet streams over the last 130 years.
DOI: 10.6084/m9.figshare.21804962.v1
title: Geomorphological map of Breiðamerkursandur 2018: the historical evolution of an active temperate glacier foreland

description: We present a geomorphological map of Breiðamerkursandur, the outwash plain and foreland of Breiðamerkurjökull, an outlet glacier of the Vatnajökull ice cap, Southeast Iceland. We trace the glacial retreat of the glacier snout since its historical late nineteenth century Little Ice Age (LIA) maximum extent and the concomitant development of the glacial drainage pathways. Since the outlet began retreating from its LIA terminal position, a 120 km<sup>2</sup> area of foreland has been exposed. The mapped geomorphology is a supplementary continuation of previous surveys in the 20th century, which highlighted the geomorphology and ice margin for the years 1945, 1965 and 1998. Since the 1998 landsystem map, Breiðamerkurjökull has retreated a further 0.6–4.0 km and 29 km<sup>2</sup> has been exposed. This new map was prepared with the use of remote sensing, LiDAR DEM, a range of oblique aerial photographs and satellite images, written documents, in-field survey measurements and refined landform classifications to more accurately trace the position of the retreating snout and its outlet streams over the last 130 years.
DOI: 10.7910/dvn/nprxew
title: Cancer Research And Textbook

description: Research and textbook about cancer
DOI: 10.5281/zenodo.7500531
title: Dataset related to article "Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer "

description: This record contains raw data related to article “Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer" Abstract <strong>Objectives: </strong> To test the hypothesis of a relationship between a specific genetic lesion (T2:ERG) and imaging scores, such as PI-RADS and PRI-MUS, and to test the effectiveness of these parameters for the diagnosis of prostate cancer (PCa) and clinically significant PCa (csPCa). <strong>Materials and methods: </strong> This is a prospective study of men with suspected PCa enrolled between 2016 and 2019 at a high-volume tertiary hospital. Patients underwent systematic US-guided biopsy, plus targeted biopsy if they were presenting with &gt;=1 suspicious lesion (PI-RADS&gt;2) at mpMRI or PR-IMUS &gt;2 at micro-ultrasound assessment. For each patient, one core from the highest PI-RADS or PRI-MUS lesion was collected for T2:ERG analysis. Multivariable logistic regression models (LRMs) were fitted for csPCa with a clinical model (age, total PSA, previous biopsy, family history for PCa), a clinical plus PI-RADS, clinical plus T2:ERG, clinical plus PI-RADS plus T2:ERG, and T2:ERG plus PI-RADS alone. <strong>Results: </strong> The cohort consists of 158 patients: 83.5% and 66.2% had respectively a diagnosis of PCa and csPCa after biopsy. A T2:ERG fusion was found in 37 men and 97.3% of these patients harbored PCa, while 81.1% were diagnosed with csPCa. SE of T2:ERG assay for csPCa was 28.8%, SP 87.0%, NPV 38.8%, and PPV 81.1%. Of 105 patients who performed mpMRI 93.% had PIRADS ≥3. SE of mpMRI for csPCa was 98.5%, SP was 12.8%, NPV was 83.3%, and PPV was 65.7%. Among 67 patients who were subjected to micro-US, 90% had a PRI-MUS ≥3. SE of micro-US for csPCa was 89.1%, SP was 9.52%, NPV was 28.6%, and PPV was 68.3%. At univariable LRM T2:ERG was confirmed as independent of mpMRI and micro-US result (OR 1.49, p=0.133 and OR 1.82, p=0.592, respectively). At multivariable LRM the clinical model alone had an AUC for csPCa of 0.74 while the clinical model including PI-RADS and T2:ERG achieved an AUC of 0.83. <strong>Conclusions: </strong> T2:ERG translocation and imaging results are independent of each other, but both are related csPCa. To evaluate the best diagnostic work-up for PCa and csPCa detection, all available tools (T2:ERG detection and imaging techniques) should be employed together as they appear to have a complementary role.
DOI: 10.5281/zenodo.7500530
title: Dataset related to article "Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer "

description: This record contains raw data related to article “Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer" Abstract <strong>Objectives: </strong> To test the hypothesis of a relationship between a specific genetic lesion (T2:ERG) and imaging scores, such as PI-RADS and PRI-MUS, and to test the effectiveness of these parameters for the diagnosis of prostate cancer (PCa) and clinically significant PCa (csPCa). <strong>Materials and methods: </strong> This is a prospective study of men with suspected PCa enrolled between 2016 and 2019 at a high-volume tertiary hospital. Patients underwent systematic US-guided biopsy, plus targeted biopsy if they were presenting with &gt;=1 suspicious lesion (PI-RADS&gt;2) at mpMRI or PR-IMUS &gt;2 at micro-ultrasound assessment. For each patient, one core from the highest PI-RADS or PRI-MUS lesion was collected for T2:ERG analysis. Multivariable logistic regression models (LRMs) were fitted for csPCa with a clinical model (age, total PSA, previous biopsy, family history for PCa), a clinical plus PI-RADS, clinical plus T2:ERG, clinical plus PI-RADS plus T2:ERG, and T2:ERG plus PI-RADS alone. <strong>Results: </strong> The cohort consists of 158 patients: 83.5% and 66.2% had respectively a diagnosis of PCa and csPCa after biopsy. A T2:ERG fusion was found in 37 men and 97.3% of these patients harbored PCa, while 81.1% were diagnosed with csPCa. SE of T2:ERG assay for csPCa was 28.8%, SP 87.0%, NPV 38.8%, and PPV 81.1%. Of 105 patients who performed mpMRI 93.% had PIRADS ≥3. SE of mpMRI for csPCa was 98.5%, SP was 12.8%, NPV was 83.3%, and PPV was 65.7%. Among 67 patients who were subjected to micro-US, 90% had a PRI-MUS ≥3. SE of micro-US for csPCa was 89.1%, SP was 9.52%, NPV was 28.6%, and PPV was 68.3%. At univariable LRM T2:ERG was confirmed as independent of mpMRI and micro-US result (OR 1.49, p=0.133 and OR 1.82, p=0.592, respectively). At multivariable LRM the clinical model alone had an AUC for csPCa of 0.74 while the clinical model including PI-RADS and T2:ERG achieved an AUC of 0.83. <strong>Conclusions: </strong> T2:ERG translocation and imaging results are independent of each other, but both are related csPCa. To evaluate the best diagnostic work-up for PCa and csPCa detection, all available tools (T2:ERG detection and imaging techniques) should be employed together as they appear to have a complementary role.
DOI: 10.7910/dvn/tbkdc4
title: Stem cell: For Researchers

description: New information and research related to stem cells in the following fields: Physiology Embryonic stem cells Amniotic Fetal stem cells Adult stem cells Dental stem Cancer stem cells .Stem cells, skeletal muscle regeneration, and bone formation Neuroscience and stem cell Neuroimaging
DOI: 10.6084/m9.figshare.21789275.v1
title: Supplementary Material for: Recommendations for Peripherally Inserted Central Catheter Insertion Depths in Neonates

description: <b><i>Objective:</i></b> Malposition of peripherally inserted central catheters (PICCs) is common. Recommendations for PICC insertion depths are scarce and comprise complex equations. This study aimed to develop diagrams and tables for the recommendation of PICC insertion depths in neonates based on anthropometric parameters. <b><i>Study Design:</i></b> In this retrospective single-center study, the individual optimal PICC insertion depths were correlated with body weight, length, and head circumference. Using linear regression analysis, line charts and tables for the recommendation of PICC insertion depth were generated and compared with previously published recommendations. <b><i>Result:</i></b> PICC insertion depths of 204 infants (gestational age at PICC installation: 24.0–44.9 weeks) with 131 (64%) PICC in the upper extremities and 73 (36%) in the lower extremities were analyzed. Linear logistic regression models revealed <i>R</i><sup>2</sup> values between 0.387 and 0.884. <b><i>Conclusion:</i></b> The charts and table developed in this study enable a fast and accurate determination of recommended PICC insertion depths in neonates.
DOI: 10.5281/zenodo.7500576
title: Dataset related to article "Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study "

description: This record contains raw data related to article “Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study" Abstract <strong>Objectives: </strong> To test the hypothesis that patients under active surveillance (AS) for Non-muscle Invasive Bladder Cancer (NMIBC) who were negative on longitudinal re-testing by the Xpert<sup>®</sup> Bladder Cancer Monitor (Xpert BC Monitor) assay may avoid unnecessary cystoscopies and urine cytology (UC). <strong>Subjects/patients or materials and methods: </strong> This is a prospective cohort study of patients enrolled in the AS protocol for recurrent NMIBC (Bladder Cancer Italian Active Surveillance, BIAS project), whose urine samples were analyzed by Xpert BC Monitor upon entry in the study (T0). Patients who had a negative Xpert test and did not fail AS, underwent additional Xpert tests after 4 (T1), 8 (T2), and 12 (T3) months. The clinical utility of Xpert was assessed by determining the number of cystoscopies and UC that could be avoided within 1 year. <strong>Results: </strong> Overall, 139 patients were tested with Xpert at T0. Median follow-up was 23 (IQR 17-27) months. Sixty-eight (48.9%) patients failed AS, 65 (46.7%) are currently on AS, and 6 (4.3%) were lost at follow-up. At T0 57 (41.0%) patients had a negative test and 36 (63.2%) are still in AS. In patients with 2 consecutives negative Xpert tests, we could have avoided 73.9% of unnecessary cystoscopies, missing 26.4% failure, up to avoid all cystoscopies with 4 negative tests missing only 12% of failure. All the patients with negative Xpert had negative UC. Failure-free-survival at median follow-up (23 month) stratified for having 0, 1, or ≥2 negative tests was 67.0, 55.1. and 84.1, respectively. <strong>Conclusion: </strong> Our findings suggest that Xpert BC Monitor assay, when it is longitudinally repeated, could significantly reduce the number of unnecessary cystoscopies and UC during their follow-up.
DOI: 10.5281/zenodo.7500575
title: Dataset related to article "Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study "

description: This record contains raw data related to article “Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study" Abstract <strong>Objectives: </strong> To test the hypothesis that patients under active surveillance (AS) for Non-muscle Invasive Bladder Cancer (NMIBC) who were negative on longitudinal re-testing by the Xpert<sup>®</sup> Bladder Cancer Monitor (Xpert BC Monitor) assay may avoid unnecessary cystoscopies and urine cytology (UC). <strong>Subjects/patients or materials and methods: </strong> This is a prospective cohort study of patients enrolled in the AS protocol for recurrent NMIBC (Bladder Cancer Italian Active Surveillance, BIAS project), whose urine samples were analyzed by Xpert BC Monitor upon entry in the study (T0). Patients who had a negative Xpert test and did not fail AS, underwent additional Xpert tests after 4 (T1), 8 (T2), and 12 (T3) months. The clinical utility of Xpert was assessed by determining the number of cystoscopies and UC that could be avoided within 1 year. <strong>Results: </strong> Overall, 139 patients were tested with Xpert at T0. Median follow-up was 23 (IQR 17-27) months. Sixty-eight (48.9%) patients failed AS, 65 (46.7%) are currently on AS, and 6 (4.3%) were lost at follow-up. At T0 57 (41.0%) patients had a negative test and 36 (63.2%) are still in AS. In patients with 2 consecutives negative Xpert tests, we could have avoided 73.9% of unnecessary cystoscopies, missing 26.4% failure, up to avoid all cystoscopies with 4 negative tests missing only 12% of failure. All the patients with negative Xpert had negative UC. Failure-free-survival at median follow-up (23 month) stratified for having 0, 1, or ≥2 negative tests was 67.0, 55.1. and 84.1, respectively. <strong>Conclusion: </strong> Our findings suggest that Xpert BC Monitor assay, when it is longitudinally repeated, could significantly reduce the number of unnecessary cystoscopies and UC during their follow-up.
DOI: 10.34740/kaggle/dsv/4801934
title: Soyabean Disease Dataset